Valeant shares fall as Ackman exit highlights company's challenges

BOSTON (Reuters) - Valeant Pharmaceuticals Inc's stock price fell to its lowest level in eight years on Tuesday after the abrupt exit of its biggest supporter put renewed focus on the Canadian...